Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year (SEAVUE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03464136
Recruitment Status : Completed
First Posted : March 13, 2018
Last Update Posted : July 7, 2021
Sponsor:
Information provided by (Responsible Party):
Janssen Scientific Affairs, LLC

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 15, 2020
Actual Study Completion Date : May 21, 2021